Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tigger transposable element-derived protein 7 (TIGD7) is a protein-coding gene in humans. The gene encodes a protein that belongs to the tigger subfamily of the pogo superfamily of DNA-mediated transposons. These proteins are distantly related to transposases found in other species, such as fungi and nematodes, and exhibit high similarity to the mammalian centromere protein B. TIGD7 has been annotated with nucleic acid binding function, but its precise biological role in humans remains unknown. Mutations or variations in TIGD7 have been associated, by genetic linkage, with developmental and bone diseases such as Holoprosencephaly 12 and Osteogenesis imperfecta, type VII. TIGD7 is not classified as a typical therapeutic target such as a receptor, enzyme, transporter, or channel, and there is no evidence of interacting drugs or mechanisms of drug action. It is mostly referenced in the context of molecular genetics studies or as a target for research reagents (e.g., antibodies for protein detection). TIGD7 is sometimes referred to by the alias “Sancho.” There are no known safety concerns or established uses as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tigger transposable element-derived protein 7 (TIGD7).